@andreshuertas.bsky.social
Radiation Oncologist, SABR enthusiast, Man United desperate fan
Congratulations to Pr David Sebag-Montefiore for the amazing results of de-escalation in the PLATO-ACT4 trial presented at #ESTRO25 !
Do we have a new standard of care for T1-T2 (up to 4 cm) anal canal cancers?
Do we have a new standard of care for T1-T2 (up to 4 cm) anal canal cancers?
May 4, 2025 at 10:14 AM
Congratulations to Pr David Sebag-Montefiore for the amazing results of de-escalation in the PLATO-ACT4 trial presented at #ESTRO25 !
Do we have a new standard of care for T1-T2 (up to 4 cm) anal canal cancers?
Do we have a new standard of care for T1-T2 (up to 4 cm) anal canal cancers?
The optimal treatment of ultracentral lung tumors is still a matter of discussion in the lung Radiation Oncology community.
Along with Dr Shankar Siva and Dr Drew Moghanaki, we discussed the notion of "acceptable toxicity" for ultracentral SBRT.
Keep it 60 Gy in 15 fractions !
Along with Dr Shankar Siva and Dr Drew Moghanaki, we discussed the notion of "acceptable toxicity" for ultracentral SBRT.
Keep it 60 Gy in 15 fractions !
Comment on Wu et al’s article on toxicity in patients receiving radiotherapy for ultracentral stage I non-small cell lung cancer
We reviewed the article by Wu et al. with great interest [1]. This secondary analysis
of the LUSTRE randomized trial focused on toxicity in patients receiving radiotherapy
for ultracentral (UC) lesion...
www.thegreenjournal.com
February 26, 2025 at 5:15 PM
The optimal treatment of ultracentral lung tumors is still a matter of discussion in the lung Radiation Oncology community.
Along with Dr Shankar Siva and Dr Drew Moghanaki, we discussed the notion of "acceptable toxicity" for ultracentral SBRT.
Keep it 60 Gy in 15 fractions !
Along with Dr Shankar Siva and Dr Drew Moghanaki, we discussed the notion of "acceptable toxicity" for ultracentral SBRT.
Keep it 60 Gy in 15 fractions !